Replimune Group, Inc. — Director's Dealing 2019

Nov 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-10-31

Reporting Person: Astley-Sparke Philip (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-31	Common Stock	S	14500	$17.00	Disposed	1413297	Direct

Footnotes

F1: The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,413,297 shares of the Issuer's common stock. The reporting person also holds options to acquire 382,571 shares of the Issuer's common stock, 94,103 of which are exercisable as of the date hereof.